These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10325825)

  • 41. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
    Bauer J; Beedgen B; Böhler T; Sontheimer D; Zilow EP; Linderkamp O
    Klin Padiatr; 1996; 208(2):56-60. PubMed ID: 8901183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
    Merz U; Pfäffle R; Peschgens T; Hörnchen H
    Z Geburtshilfe Neonatol; 1997; 201(6):253-7. PubMed ID: 9491545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.
    Yeh TF; Lin YJ; Lin HC; Huang CC; Hsieh WS; Lin CH; Tsai CH
    N Engl J Med; 2004 Mar; 350(13):1304-13. PubMed ID: 15044641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of dexamethasone on leukocyte numbers and lymphocyte-blastogenic responses to mitogens in infants with bronchopulmonary dysplasia.
    Moya FR; Becerra M; Leiva L; Sorensen RU
    Clin Pediatr (Phila); 1993 Mar; 32(3):185-8. PubMed ID: 8453841
    [No Abstract]   [Full Text] [Related]  

  • 45. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C; Bertini G; Simone P; Rubaltelli FF
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract]   [Full Text] [Related]  

  • 46. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
    Kari MA; Heinonen K; Ikonen RS; Koivisto M; Raivio KO
    Arch Dis Child; 1993 May; 68(5 Spec No):566-9. PubMed ID: 8323356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steroids, chronic lung disease, and retinopathy of prematurity.
    Ehrenkranz RA
    Pediatrics; 1992 Oct; 90(4):646-7. PubMed ID: 1408525
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hypertrophic cardiomyopathy in a low-birth-weight newborn treated with dexamethasone].
    Villa Alcázar M; Pellicer Martínez A; Burgueros Valero M; Quero Jiménez J
    An Esp Pediatr; 1996 Apr; 44(4):393-4. PubMed ID: 8796947
    [No Abstract]   [Full Text] [Related]  

  • 49. Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia?
    Eichenwald EC; Stark AR
    Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F334-7. PubMed ID: 17712183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants.
    Kersbergen KJ; de Vries LS; van Kooij BJ; Išgum I; Rademaker KJ; van Bel F; Hüppi PS; Dubois J; Groenendaal F; Benders MJ
    J Pediatr; 2013 Sep; 163(3):666-71.e1. PubMed ID: 23706359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NO for preterm infants at risk of bronchopulmonary dysplasia.
    Sosenko IR; Bancalari E
    Lancet; 2010 Jul; 376(9738):308-10. PubMed ID: 20655103
    [No Abstract]   [Full Text] [Related]  

  • 52. Postnatal glucocorticoids in preterm neonates: use in French neonatal centres in 2006.
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Dis Child Fetal Neonatal Ed; 2008 Sep; 93(5):F398. PubMed ID: 18723787
    [No Abstract]   [Full Text] [Related]  

  • 53. Neurological adverse effects of early postnatal dexamethasone in very preterm infants.
    Baud O; Zupan V; Lacaze-Masmonteil T; Dehan M
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F159. PubMed ID: 10325800
    [No Abstract]   [Full Text] [Related]  

  • 54. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ; Brans YW; Poland RL
    Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
    Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchopulmonary dysplasia: treatment success with dexamethasone.
    Hearne AB
    J Natl Med Assoc; 1982 Aug; 74(8):795-800. PubMed ID: 7131578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone.
    D'Angio CT; Maniscalco WM; Ryan RM; Avissar NE; Basavegowda K; Sinkin RA
    Biol Neonate; 1999 Nov; 76(5):266-73. PubMed ID: 10516393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome.
    Sanders RJ; Cox C; Phelps DL; Sinkin RA
    Pediatr Res; 1994 Jul; 36(1 Pt 1):122-8. PubMed ID: 7936832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bronchopulmonary dysplasia and corticosteroid therapy: a case review.
    Doyle P
    Neonatal Netw; 1996 Sep; 15(6):35-40. PubMed ID: 8932070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On dexamethasone in bronchopulmonary dysplasia.
    Frank L
    Pediatr Pulmonol; 1994 Mar; 17(3):205-6. PubMed ID: 8197003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.